Augmenix, Inc.

Booth #405
Harbour Ballroom

Visit Website

SpaceOAR® hydrogel is a prostate-rectum spacer that separates and protects the rectum during prostate radiotherapy, decreasing rectal toxicity and minimize changes in quality of life. SpaceOAR hydrogel is FDA cleared, CE marked, approved in Australia and Japan and licensed in Canada. Augmenix was recently acquired by Boston Scientific.


© 2020 CUOS 2019